Зазуля Анатолий Викторович (RU);Зазуля Владимир Анатольевич (RU)
发明人:
Зазуля Анатолий Викторович (RU),Зазуля Владимир Анатольевич (RU)
申请号：
RU2017110012
公开号：
RU2017110012A
申请日:
2016.05.10
申请国别(地区):
RU
年份:
2020
代理人:
摘要：
The combination of individual separate delivery routes for solid therapeutic dose orally or a subtherapeutic liquid dose sublingually is a qualitatively new structural pharmacotherapy unit enabling the postadaptation hormesis effect. The advantage of the new drug form is elimination of the pre-systemic metabolism effect in liver with a subtherapeutic dose along with systemic bioavailability enhancement, prevention of drug destruction by chlorobutanol acid in the stomach and by alkaline contents in the intestines, and body resistance improvement.
